[Code of Federal Regulations]
[Title 21, Volume 1]
[Revised as of April 1, 2007]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR26.75]
[Page 277]
TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN
SERVICES
PART 26 MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE
Subpart C_``Framework'' Provisions
Sec. 26.75 Suspension of recognition obligations.
Either party may suspend its obligations under subpart A or B of
this part, in whole or in part, if:
(a) A party suffers a loss of market access for the party's products
within the scope of subpart A or B of this part as a result of the
failure of the other party to fulfill its obligations under this part;
(b) The adoption of new or additional conformity assessment
requirements as referenced in Sec. 26.73(e) results in a loss of market
access for the party's products within the scope of subpart B of this
part because conformity assessment bodies (CAB's) designated by the
party in order to meet such requirements have not been recognized by the
party implementing the requirements; or
(c) The other party fails to maintain legal and regulatory
authorities capable of implementing the provisions of this part.
Back to Top
© 2007 Betterchem Corp.
|
